Back to Agenda
The Future of Precision Medicines: How the Regulatory Framework Keeps Up with Evolving Science
Session Chair(s)
Lucia D'Apote, DRSC, RAC
Executive Director Global Regulatory Policy, Amgen, Switzerland
This session will provide a platform for scientific exchange among the EMA, the EC DG Research and other global health authorities (e.g. FDA), patient advocates, and drug development innovators on the evolving global landscape for precision medicine
Learning Objective : • Foster discussions and education of the challenges and opportunities posed by precision medicines and learn about major EU and International initiatives • Understand learnings from Precision medicines programmes funded and authorized in the EU and experience of other Regulators
Speaker(s)
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator, Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Regulator Perspective
Irene Norstedt
Director - People Directorate, DG Research and Innovation, European Commission, Belgium
Antonella Cardone
Director, Cancer Patients Europe, Belgium
Christine Mayer-Nicolai, PHARMD
Vice President, Regulatory and Scientific Policy, Merck Healthcare Kgaa, Germany
Christian Schneider, DrMed
Head of Biopharma Excellence and Chief Medical Officer (Biopharma), PharmaLex, Denmark
Have an account?